Course Overview
This content was accurate at the time of release, 1 November 2021. Accreditation for this course expired on 2 November 2022. If you would still like an activity completion certificate, send your request to [email protected].
This online learning module is designed to raise awareness for HCM and provide you with an understanding of how HCM can be diagnosed and appropriately managed. It assists clinicians in community practice or those with an interest in HCM management to:
- improve HCM diagnosis and assignment of hemodynamic category
- provide appropriate management strategies for heart failure symptoms and recognise limitations
- implement strategies for sudden death prevention
- know when referral to an HCM expert center is appropriate
This online learning module is designed to be completed in 60 minutes.
Target audience
Family/general physicians, general/community cardiologists, cardiac nurses, pediatricians, pediatric nurses, genetic counselors
Funding disclosure
This activity is supported by educational grant funding from Bristol Myers Squibb, Cytokinetics and Sanofi. Learners may participate in this educational activity free of charge.
- Introduction to hypertrophic cardiomyopathy (HCM)
- Clinical presentation and symptoms
- Diagnostic criteria and features
- Natural history of disease
- Prevention of sudden death
- Managing HCM heart failure symptoms in obstructive versus non-obstructive disease
- Advanced stage disease
- Management of atrial fibrillation in HCM
By the end of this activity, attendees will be able to:
- Recall the etiology of hypertrophic cardiomyopathy (HCM) and utilize this knowledge to determine best clinical practice
- Detail the common findings in patients presenting with HCM and apply these criteria to an example patient
- Outline the echocardiography and cardiac magnetic resonance imaging features that support clinical diagnosis of HCM and apply this to sample patient data
- Classify the correct primary hemodynamic category for individual HCM patients (obstructive vs. nonobstructive) and interpret example patient data
- Explain the diagnostic differences of diseases that appear morphologically similar to HCM and employ this on example data
Accreditation for this course has expired. You may view the program, but CME/ CE is no longer available and no certificate will be issued.
Faculty disclosure:
Dr Martin Maron, MD, Director of the Hypertrophic Cardiomyopathy Center and
Research Institute at Tufts Medical Center and the Chanin T. Mast Hypertrophic
Cardiomyopathy Center in Morristown Medical Center, has received financial
compensation for consulting for Cytokinetics and Imbria, and received research
grants from Takeda and iRhythm.
Disclosure of educational planners:
Lauren Tebay, BA (mod), PhD, Senior Medical Writer, PCM Scientific, has no
relevant conflicts of interest to disclose.
Charles Turck, PharmD, BCPS, BCCCP, President of ScientiaCME, has no relevant
conflicts of interest to disclose.
All relevant financial relationships have been mitigated.